Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS<sup>TM</sup>) SARS-CoV-2 Vaccine

Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS<sup>TM</sup>) SARS-CoV-2 Vaccine

Despite the remarkable success of SARS-CoV-2 vaccines, the rise of variants, some of which are more resistant to the effects of vaccination, highlights the potential need for additional COVID-19 vaccines. We used the Multiple Antigen-Presenting System (MAPS) technology, in which proteins are present...

Full description

Bibliographic Details
Main Authors: Brian Cieslewicz, Daniel Makrinos, Heidi Burke, Dara Bree, Renuka Haridas, Ian Tonkiss, Yannic Bartsch, Galit Alter, Richard Malley, Gilles Besin
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
SARS-CoV-2 vaccine MAPS
Online Access:https://www.mdpi.com/2076-393X/10/7/1069

Internet

https://www.mdpi.com/2076-393X/10/7/1069

Similar Items